An Open-Label, Parallel-Group, Phase I Study to Compare the Pharmacokinetics of NKTR-118 Following a Single Oral Dose in Subjects With Renal Impairment and Subjects With Normal Renal Function.
Phase of Trial: Phase I
Latest Information Update: 01 Jan 2016
At a glance
- Drugs Naloxegol (Primary)
- Indications Constipation
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 22 Dec 2011 Actual end date (Nov 2011) added as reported by ClinicalTrials.gov.
- 22 Dec 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 22 Jul 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.